Toronto, Canada, Sept. 01, 2020 ( GLOBE NEWSWIRE - Link ) -- Vielight Inc. is pleased to announce the commencement of a new clinical trial in the USA. In this trial, Vielight Inc. will test the hypothesis that the recovery of patients who recently tested positive for COVID-19 infection may be accelerated by specialized light therapy. [...]
Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation.
Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation.Vielight2019-05-24T13:12:05-04:00
Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation. Toronto, ON, May 22, 2019: Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial, St. Michael’s Hospital, in Toronto, has been activated. The trial will be a randomized, placebo-controlled study [...]
Study Reveals Significant Brain Response to Vielight’s Brain Stimulation Technology Pulsing near infrared light at 40 Hz safely modulates brain waves April 23, 2019, Toronto, Canada: Over the last decade, there have been a number of studies suggesting that delivering low level laser or light into the brain could modulate and improve brain functions. This [...]